Phase 2 Trial of Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab in Resectable Non-Small Cell Lung Cancer (Neo-KAN)
Latest Information Update: 27 Nov 2024
At a glance
Most Recent Events
- 25 Nov 2024 Status changed from recruiting to active, no longer recruiting.
- 13 Apr 2023 Status changed from not yet recruiting to recruiting.
- 21 Mar 2023 Planned initiation date changed from 1 Mar 2023 to 21 Mar 2023.